Asthma-OSA overlap: shared risk factors and comorbidities.
| Modifiable treatable trait | Objective clinical assessment & clues | Recommended multidisciplinary actions |
|---|---|---|
| Obesity & metabolic dysfunction | BMI ≥ 30 kg/m2, elevated waist/neck circumference, dysregulated fasting metabolic panel. | Implement structured lifestyle and dietary modifications; refer to specialized weight-management programs; consider GLP-1/dual agonists based on obesity guidelines; serially re-evaluate AHI and asthma control scores following weight reduction. |
| Obstructive sleep apnea (OSA) | STOP-Bang score ≥ 3, elevated Epworth Sleepiness Scale (ESS ≥ 10), frequent witnessed apneas, loud snoring. | Perform diagnostic Home Sleep Testing (HST) or gold-standard laboratory PSG; initiate targeted therapy (CPAP titration, or customized oral appliances for mild/moderate cases); reassess objective asthma control post-initiation. |
| Upper airway disease & rhinitis | Persistent nasal congestion, rhinorrhea, post-nasal drip, structural ENT examination. | Treat underlying allergic/non-allergic rhinitis aggressively using intranasal corticosteroids and non-sedating antihistamines; refer to ENT for corrective structural evaluation if anatomical obstruction is present. |
| Gastroesophageal reflux disease (GERD) | Frequent nocturnal heartburn, acid regurgitation, chronic laryngopharyngeal symptoms. | Optimize behavioral anti-reflux habits (head-of-bed elevation, early dinners); initiate targeted proton pump inhibitor (PPI) therapy where clinically indicated; consider gastroenterology referral for refractory cases. |
| Poor asthma control & non-adherence | Depressed ACT/ACQ scores, poor inhaler technique observation, irregular prescription refill data. | Formally optimize inhaled pharmacological therapy; comprehensively evaluate and correct inhaler technique and medication adherence; consider step-up therapy or targeted biologics if indicated. |
| Corticosteroid over-exposure | Documentation of frequent systemic rescue bursts or chronic maintenance oral steroid use. | Implement strict steroid-sparing clinical pathways; optimize advanced non-steroidal maintenance or biologic therapies; closely monitor for progressive steroid-induced weight gain and pharyngeal muscle myopathy. |
ACT: Asthma Control Test; ACQ: Asthma Control Questionnaire; BMI: body mass index; AHI: Apnea-Hypopnea Index.